Prevalence of Extraintestinal Manifestations in Korean Inflammatory Bowel Disease Patients

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Jul 11

PMID 29990326

Citations 21

Authors

Bo Ram Yang

Nam-Kyong Choi

Mi-Sook Kim

Jaeyoung Chun

Sang Hyun Joo

Hyesung Kim

Joongyub Lee

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of inflammatory bowel disease (IBD) in South Korea is increasing. Although extraintestinal manifestations (EIMs) are an important factor in the clinical outcomes of IBD patients, EIMs have not yet been investigated in Korea. Thus, we conducted a cross-sectional study to assess the prevalence of EIMs in Korean IBD patients.

Methods: The 2014 claims data from the National Health Insurance System (NHIS) of Korea were used. IBD patients were identified by codes for Crohn disease (CD) and ulcerative colitis (UC) in the NHIS registration system for rare or intractable diseases. International Classification of Diseases, Tenth Edition codes were used to identify EIM cases. To estimate the prevalence of EIMs in the general population of Korea, we used national sample data. Standardized prevalence ratios (SPRs) were calculated to compare the prevalence rates of EIMs among IBD patients to those among the general population of Korea.

Results: A total of 13,925 CD patients and 29,356 UC patients were identified. CD and UC patients were different in terms of demographics and utilization of medication. Among the 17 EIMs investigated, pyoderma gangrenosum, osteomalacia, Sweet syndrome, and scleritis were observed in very few patients. The SPRs were greater than 1 for all EIMs. Aphthous stomatitis, rheumatoid arthritis, and osteoporosis were highly prevalent in both CD and UC patients, but the SPRs of the EIMs were not high.

Conclusion: The study confirmed that EIMs are more prevalent among IBD patients than among the general population of Korea. The prevalence of EIMs in IBD patients suggests the need for greater attention and effort in clinical practice.

Citing Articles

Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment.

Faggiani I, Fanizza J, DAmico F, Allocca M, Zilli A, Parigi T Biomedicines. 2024; 12(8).

PMID: 39200303 PMC: 11351332. DOI: 10.3390/biomedicines12081839.

Association between inflammatory bowel disease and osteoporosis in European and East Asian populations: exploring causality, mediation by nutritional status, and shared genetic architecture.

Kang J, Wu X, Li Y, Zhao S, Wang S, Yu D Front Immunol. 2024; 15:1425610.

PMID: 39136019 PMC: 11317921. DOI: 10.3389/fimmu.2024.1425610.

Inflammatory bowel disease and rheumatoid arthritis share a common genetic structure.

Cao G, Luo Q, Wu Y, Chen G Front Immunol. 2024; 15:1359857.

PMID: 38938570 PMC: 11208460. DOI: 10.3389/fimmu.2024.1359857.

Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience.

Alotaibi A, Alhubayshi A, Allehibi A, Almtawa A, Alotaibi N, Alghamdi A Saudi J Med Med Sci. 2024; 12(2):169-174.

PMID: 38764558 PMC: 11098265. DOI: 10.4103/sjmms.sjmms_139_23.

Potential role of SNP rs2071475 in rheumatoid arthritis and inflammatory bowel disease in the East Asian population: a Mendelian randomization study.

Wang B, Xiong Y, Li R, Zhang S Inflammopharmacology. 2023; 32(1):683-692.

PMID: 37855981 PMC: 10907428. DOI: 10.1007/s10787-023-01363-1.

References

Monsen U, Sorstad J, Hellers G, Johansson C . Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990; 85(6):711-6. View

Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali G . Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015; 34(5):387-94. DOI: 10.1007/s12664-015-0598-8. View

Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G . Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2006; 11(46):7227-36. PMC: 4725142. DOI: 10.3748/wjg.v11.i46.7227. View

Winther K, Jess T, Langholz E, Munkholm P, Binder V . Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology. 2004; 125(6):1576-82. DOI: 10.1053/j.gastro.2003.09.036. View

Lapidus A, Bangstad M, Astrom M, Muhrbeck O . The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol. 1999; 94(5):1261-6. DOI: 10.1111/j.1572-0241.1999.01076.x. View

von Tirpitz C, Pischulti G, Klaus J, Rieber A, Bruckel J, Bohm B . [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors]. Z Gastroenterol. 1999; 37(1):5-12. View

Ardizzone S, Bollani S, Bettica P, Bevilacqua M, MOLTENI P, Bianchi Porro G . Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000; 247(1):63-70. DOI: 10.1046/j.1365-2796.2000.00582.x. View

Cosnes J, Gower-Rousseau C, Seksik P, Cortot A . Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140(6):1785-94. DOI: 10.1053/j.gastro.2011.01.055. View

Kim J, Yoon S, Kim L, Kim D . Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. J Korean Med Sci. 2017; 32(5):718-728. PMC: 5383602. DOI: 10.3346/jkms.2017.32.5.718. View

10.

Yuksel I, Basar O, Ataseven H, Ertugrul I, Arhan M, Ibis M . Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 15(4):546-50. DOI: 10.1002/ibd.20807. View

11.

Bernstein C, Blanchard J, Rawsthorne P, Yu N . The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001; 96(4):1116-22. DOI: 10.1111/j.1572-0241.2001.03756.x. View

12.

Lee Y, KAPLAN M . Primary sclerosing cholangitis. N Engl J Med. 1995; 332(14):924-33. DOI: 10.1056/NEJM199504063321406. View

13.

Evans P, Pardi D . Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed. 2007; 9(1):55. PMC: 1925026. View

14.

Bernstein C, Leslie W, LeBoff M . AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003; 124(3):795-841. DOI: 10.1053/gast.2003.50106. View

15.

Ye B, Yang S, Boo S, Cho Y, Yang D, Yoon S . Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm Bowel Dis. 2011; 17(9):1901-6. DOI: 10.1002/ibd.21569. View

16.

Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

17.

Turkcapar N, Toruner M, Soykan I, Aydintug O, Cetinkaya H, Duzgun N . The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2005; 26(7):663-8. DOI: 10.1007/s00296-005-0044-9. View

18.

Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T . Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2016; 10(4):429-36. PMC: 4946768. DOI: 10.1093/ecco-jcc/jjv232. View

19.

Davis P, Thomson A, Lentle B . Quantitative sacroiliac scintigraphy in patients with Crohn's disease. Arthritis Rheum. 1978; 21(2):234-7. DOI: 10.1002/art.1780210210. View

20.

Orchard T, Wordsworth B, Jewell D . Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998; 42(3):387-91. PMC: 1727027. DOI: 10.1136/gut.42.3.387. View